Literature DB >> 16105755

NUP98 fusion in human leukemia: dysregulation of the nuclear pore and homeodomain proteins.

Takuro Nakamura1.   

Abstract

NUP98 is fused to a variety of partner genes, including abdominal B-like HOX, in human myeloid and T-cell malignancies via chromosomal translocation involving 11p15. NUP98 encodes a 98-kd nucleoporin that is a component of the nuclear pore complex and functions in nucleocytoplasmic transport, with its N-terminal GLFG repeats used as a docking site for karyopherins. Disruption of NUP98 may affect the nuclear pore function, and the abnormal expression and altered function of fusion partners may also be critical for leukemia development. Recent studies using mouse models expressing NUP98-HOX have confirmed its leukemogenic potential, and cooperative genes for NUP98-HOXA9 in leukemogenesis have been identified in these studies.Thus, the NUP98 chimera is a unique molecule that provides valuable information regarding nuclear pore function and the role of the homeobox protein in leukemogenesis/carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16105755     DOI: 10.1532/IJH97.04160

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  77 in total

1.  NUP98 is fused to the NSD3 gene in acute myeloid leukemia associated with t(8;11)(p11.2;p15).

Authors:  Roberto Rosati; Roberta La Starza; Angelo Veronese; Ana Aventin; Christine Schwienbacher; Teresa Vallespi; Massimo Negrini; Massimo F Martelli; Cristina Mecucci
Journal:  Blood       Date:  2002-05-15       Impact factor: 22.113

2.  Pores for thought: nuclear pore complex proteins.

Authors:  M P Rout; S R Wente
Journal:  Trends Cell Biol       Date:  1994-10       Impact factor: 20.808

Review 3.  Dynein and dynein-related genes.

Authors:  I Milisav
Journal:  Cell Motil Cytoskeleton       Date:  1998

4.  Lineage-specific regulation of hematopoiesis by HOX-B8 (HOX-2.4): inhibition of granulocytic differentiation and potentiation of monocytic differentiation.

Authors:  K Krishnaraju; B Hoffman; D A Liebermann
Journal:  Blood       Date:  1997-09-01       Impact factor: 22.113

5.  NUP98 is fused to PMX1 homeobox gene in human acute myelogenous leukemia with chromosome translocation t(1;11)(q23;p15).

Authors:  T Nakamura; Y Yamazaki; Y Hatano; I Miura
Journal:  Blood       Date:  1999-07-15       Impact factor: 22.113

6.  Calcium-mediated structural changes of native nuclear pore complexes monitored by time-lapse atomic force microscopy.

Authors:  D Stoffler; K N Goldie; B Feja; U Aebi
Journal:  J Mol Biol       Date:  1999-04-09       Impact factor: 5.469

Review 7.  Retroviral insertional mutagenesis: tagging cancer pathways.

Authors:  Harald Mikkers; Anton Berns
Journal:  Adv Cancer Res       Date:  2003       Impact factor: 6.242

8.  NUP98 is fused to adducin 3 in a patient with T-cell acute lymphoblastic leukemia and myeloid markers, with a new translocation t(10;11)(q25;p15).

Authors:  Idoya Lahortiga; José L Vizmanos; Xabier Agirre; Iria Vázquez; Juan C Cigudosa; María J Larrayoz; Francisco Sala; Ana Gorosquieta; Katy Perez-Equiza; María J Calasanz; María D Odero
Journal:  Cancer Res       Date:  2003-06-15       Impact factor: 12.701

9.  NUP98-HOXD13 gene fusion in therapy-related acute myelogenous leukemia.

Authors:  S Z Raza-Egilmez; S N Jani-Sait; M Grossi; M J Higgins; T B Shows; P D Aplan
Journal:  Cancer Res       Date:  1998-10-01       Impact factor: 12.701

10.  Proteomic analysis of the mammalian nuclear pore complex.

Authors:  Janet M Cronshaw; Andrew N Krutchinsky; Wenzhu Zhang; Brian T Chait; Michael J Matunis
Journal:  J Cell Biol       Date:  2002-08-26       Impact factor: 10.539

View more
  14 in total

1.  mRNA nuclear export and human disease.

Authors:  Jessica A Hurt; Pamela A Silver
Journal:  Dis Model Mech       Date:  2008 Sep-Oct       Impact factor: 5.758

2.  Enhanced expression of the EVI1 gene in NUP98/HOXA-expressing leukemia cells.

Authors:  Minenori Eguchi-Ishimae; Mariko Eguchi; Kazuma Ohyashiki; Tetsuya Yamagata; Kinuko Mitani
Journal:  Int J Hematol       Date:  2009-02-26       Impact factor: 2.490

3.  c-Myb is an essential downstream target for homeobox-mediated transformation of hematopoietic cells.

Authors:  Jay L Hess; Claudia B Bittner; Deniz T Zeisig; Christian Bach; Uta Fuchs; Arndt Borkhardt; Jon Frampton; Robert K Slany
Journal:  Blood       Date:  2006-02-28       Impact factor: 22.113

4.  MEIS1-mediated transactivation of synaptotagmin-like 1 promotes CXCL12/CXCR4 signaling and leukemogenesis.

Authors:  Takashi Yokoyama; Mayuka Nakatake; Takeshi Kuwata; Arnaud Couzinet; Ryo Goitsuka; Shuichi Tsutsumi; Hiroyuki Aburatani; Peter J M Valk; Ruud Delwel; Takuro Nakamura
Journal:  J Clin Invest       Date:  2016-03-28       Impact factor: 14.808

5.  Up-regulation of homeodomain genes, DLX1 and DLX2, by FLT3 signaling.

Authors:  Julia Starkova; Sharvari Gadgil; Yi Hua Qiu; Nianxiang Zhang; Ivana Hermanova; Steven M Kornblau; Harry A Drabkin
Journal:  Haematologica       Date:  2011-02-28       Impact factor: 9.941

6.  Donor cell-derived chronic myeloproliferative disease with t(7;11)(p15;p15) after cord blood transplantation in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia.

Authors:  Hideki Mitsui; Tsuyoshi Nakazawa; Akira Tanimura; Takahiro Karasuno; Akira Hiraoka
Journal:  Int J Hematol       Date:  2007-08       Impact factor: 2.490

Review 7.  Virological and cellular roles of the transcriptional coactivator LEDGF/p75.

Authors:  Manuel Llano; James Morrison; Eric M Poeschla
Journal:  Curr Top Microbiol Immunol       Date:  2009       Impact factor: 4.291

8.  A multidimensional analysis of genes mutated in breast and colorectal cancers.

Authors:  Jimmy Lin; Christine M Gan; Xiaosong Zhang; Siân Jones; Tobias Sjöblom; Laura D Wood; D Williams Parsons; Nickolas Papadopoulos; Kenneth W Kinzler; Bert Vogelstein; Giovanni Parmigiani; Victor E Velculescu
Journal:  Genome Res       Date:  2007-08-10       Impact factor: 9.043

9.  Nucleoporin levels regulate cell cycle progression and phase-specific gene expression.

Authors:  Papia Chakraborty; Yaming Wang; Jen-Hsuan Wei; Jan van Deursen; Hongtao Yu; Liviu Malureanu; Mary Dasso; Douglass J Forbes; David E Levy; Joachim Seemann; Beatriz M A Fontoura
Journal:  Dev Cell       Date:  2008-11       Impact factor: 12.270

10.  Blast crisis Ph+ chronic myeloid leukemia with NUP98/HOXA13 up-regulating MSI2.

Authors:  Danika Di Giacomo; Valentina Pierini; Gianluca Barba; Veronica Ceccarelli; Alba Vecchini; Cristina Mecucci
Journal:  Mol Cytogenet       Date:  2014-06-20       Impact factor: 2.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.